Registro:

Referencias:

• Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Bray, F., Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 (2015) Int J Cancer, 136, pp. E359-E386. , https://doi.org/10.1002/ijc.29210
• Bass, A.J., Thorsson, V., Shmulevich, I., Reynolds, S.M., Miller, M., Bernard, B., Hinoue, T., Shen, R., Comprehensive molecular characterization of gastric adenocarcinoma (2014) Nature, 513, pp. 202-209. , https://doi.org/10.1038/nature13480
• Garg, H., Suri, P., Gupta, J.C., Talwar, G.P., Dubey, S., Survivin: a unique target for tumor therapy (2016) Cancer Cell Int, 16, p. 49. , https://doi.org/10.1186/s12935-016-0326-1
• Cheung, C.H., Huang, C.C., Tsai, F.Y., Lee, J.Y., Cheng, S.M., Chang, Y.C., Huang, Y.C., Chang, J.Y., Survivin-biology and potential as a therapeutic target in oncology (2013) Onco Targets Ther, 6, pp. 1453-1462. , https://doi.org/10.2147/ott.s33374
• Valenzuela, M., Bravo, D., Canales, J., Sanhueza, C., Diaz, N., Almarza, O., Toledo, H., Quest, A.F., Helicobacter pylori-induced loss of survivin and gastric cell viability is attributable to secreted bacterial gamma-glutamyl transpeptidase activity (2013) J Infect Dis, 208, pp. 1131-1141. , https://doi.org/10.1093/infdis/jit286
• Valenzuela, M., Perez-Perez, G., Corvalan, A.H., Carrasco, G., Urra, H., Bravo, D., Toledo, H., Quest, A.F., Helicobacter pyloriinduced loss of the inhibitor-of-apoptosis protein survivin is linked to gastritis and death of human gastric cells (2010) J Infect Dis, 202, pp. 1021-1030. , https://doi.org/10.1086/656143
• Chun-Lai, T., Murad, S., Erlandsson, M.C., Hussein, H., Sulaiman, W., Dhaliwal, J.S., Bokarewa, M.I., Recognizing rheumatoid arthritis: oncoprotein survivin opens new possibilities: a population-based case-control study (2015) Medicine (Baltimore), 94, p. e468. , https://doi.org/10.1097/md.0000000000000468
• Bertazza, L., Mocellin, S., Marchet, A., Pilati, P., Gabrieli, J., Scalerta, R., Nitti, D., Survivin gene levels in the peripheral blood of patients with gastric cancer independently predict survival (2009) J Transl Med, 7, p. 111. , https://doi.org/10.1186/1479-5876-7-111
• Jiang, Y., Saavedra, H.I., Holloway, M.P., Leone, G., Altura, R.A., Aberrant regulation of survivin by the RB/E2F family of proteins (2004) J Biol Chem, 279, pp. 40511-40520. , https://doi.org/10.1074/jbc.M404496200
• Xu, R., Zhang, P., Huang, J., Ge, S., Lu, J., Qian, G., Sp1 and Sp3 regulate basal transcription of the survivin gene (2007) Biochem Biophys Res Commun, 356, pp. 286-292. , https://doi.org/10.1016/j.bbrc.2007.02.140
• Hoffman, W.H., Biade, S., Zilfou, J.T., Chen, J., Murphy, M., Transcriptional repression of the anti-apoptotic survivin gene by wild type p53 (2002) J Biol Chem, 277, pp. 3247-3257. , https://doi.org/10.1074/jbc.M106643200
• Busuttil, R.A., Zapparoli, G.V., Haupt, S., Fennell, C., Wong, S.Q., Pang, J.M., Takeno, E.A., Boussioutas, A., Role of p53 in the progression of gastric cancer (2014) Oncotarget, 5, pp. 12016-12026. , https://doi.org/10.18632/oncotarget.2434
• Jung, C.L., Mun, H., Jo, S.Y., Oh, J.H., Lee, C., Choi, E.K., Jang, S.J., Suh, Y.A., Suppression of gain-of-function mutant p53 with metabolic inhibitors reduces tumor growth in vivo (2016) Oncotarget, 7, pp. 77664-77682. , https://doi.org/10.18632/oncotarget.12758
• Tsuji, N., Furuse, K., Asanuma, K., Furuya, M., Kondoh, K., Kamagata, C., Sasaki, M., Watanabe, N., Mutations of the p53 gene and loss of heterozygosity at chromosome 17p13.1 are associated with increased survivin expression in breast cancer (2004) Breast Cancer Res Treat, 87, pp. 23-31. , https://doi.org/10.1023/B:BREA.0000041575.73262.aa
• Xu, Y., Fang, F., Ludewig, G., Jones, G., Jones, D., A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells (2004) DNA Cell Biol, 23, pp. 527-537. , https://doi.org/10.1089/dna.2004.23.527
• Yeo, K.S., Mohidin, T.B., Ng, C.C., Epstein-Barr virus-encoded latent membrane protein-1 upregulates 14-3-3sigma and Reprimo to confer G(2)/M phase cell cycle arrest (2012) C R Biol, 335, pp. 713-721. , https://doi.org/10.1016/j.crvi.2012.11.002
• Malik, S., Jiang, S., Garee, J.P., Verdin, E., Lee, A.V., O'Malley, B.W., Zhang, M., Oesterreich, S., Histone deacetylase 7 and FoxA1 in estrogen-mediated repression of RPRM (2010) Mol Cell Biol, 30, pp. 399-412. , https://doi.org/10.1128/mcb.00907-09
• Xu, M., Knox, A.J., Michaelis, K.A., Kiseljak-Vassiliades, K., Kleinschmidt-DeMasters, B.K., Lillehei, K.O., Wierman, M.E., Reprimo (RPRM) is a novel tumor suppressor in pituitary tumors and regulates survival, proliferation, and tumorigenicity (2012) Endocrinology, 153, pp. 2963-2973. , https://doi.org/10.1210/en.2011-2021
• Luo, J., Zhu, Y., Yang, G., Gong, L., Wang, B., Liu, H., Loss of reprimo and S100A2 expression in human gastric adenocarcinoma (2011) Diagn Cytopathol, 39, pp. 752-757. , https://doi.org/10.1002/dc.21461
• Saavedra, K., Valbuena, J., Olivares, W., Marchant, M.J., Rodriguez, A., Torres-Estay, V., Carrasco-Avino, G., Corvalan, A.H., Loss of expression of reprimo, a p53-induced cell cycle arrest gene, correlates with invasive stage of tumor progression and p73 expression in gastric cancer (2015) PLoS One, 10. , https://doi.org/10.1371/journal.pone.0125834
• Garcia-Bloj, B., Moses, C., Sgro, A., Plani-Lam, J., Arooj, M., Duffy, C., Thiruvengadam, S., Corvalan, A.H., Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system (2016) Oncotarget, 7, pp. 60535-60554. , https://doi.org/10.18632/oncotarget.11142
• Schneider, B.G., Peng, D.F., Camargo, M.C., Piazuelo, M.B., Sicinschi, L.A., Mera, R., Romero-Gallo, J., El-Rifai, W., Promoter DNA hypermethylation in gastric biopsies from subjects at high and low risk for gastric cancer (2010) Int J Cancer, 127, pp. 2588-2597. , https://doi.org/10.1002/ijc.25274
• Wang, Q.P., Wang, Y., Wang, X.D., Mo, X.M., Gu, J., Lu, Z.Y., Pan, Z.L., Zhu, Y.X., Survivin up-regulates the expression of breast cancer resistance protein (BCRP) through attenuating the suppression of p53 on NF-kappaB expression in MCF-7/5-FU cells (2013) Int J Biochem Cell Biol, 45, pp. 2036-2044. , https://doi.org/10.1016/j.biocel.2013.06.026
• Huang, G., Meng, L., Tsai, R.Y., p53 configures the G2/M arrest response of nucleostemin-deficient cells (2015) Cell Death Dis, 1. , https://doi.org/10.1038/cddiscovery.2015.60
• Shi, Y., Chen, C., Zhang, X., Liu, Q., Xu, J.L., Zhang, H.R., Yao, X.H., Liu, L., Primate-specific miR-663 functions as a tumor suppressor by targeting PIK3CD and predicts the prognosis of human glioblastoma (2014) Clin Cancer Res, 20, pp. 1803-1813. , https://doi.org/10.1158/1078-0432.ccr-13-2284
• Figueiredo, C., Costa, S., Karameris, A., Machado, J.C., Pathogenesis of gastric cancer (2015) Helicobacter, 20, pp. 30-35. , https://doi.org/10.1111/hel.12254
• Cerami, E., Gao, J., Dogrusoz, U., Gross, B.E., Sumer, S.O., Aksoy, B.A., Jacobsen, A., Goldberg, A.P., The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data (2012) Cancer Discov, 2, pp. 401-404. , https://doi.org/10.1158/2159-8290.cd-12-0095
• Torres, V.A., Tapia, J.C., Rodriguez, D.A., Parraga, M., Lisboa, P., Montoya, M., Leyton, L., Quest, A.F., Caveolin-1 controls cell proliferation and cell death by suppressing expression of the inhibitor of apoptosis protein survivin (2006) J Cell Sci, 119, pp. 1812-1823. , https://doi.org/10.1242/jcs.02894
• Li, N., Xie, C., Lu, N.H., p53, a potential predictor of helicobacter pylori infection-associated gastric carcinogenesis? (2016) Oncotarget, 7, pp. 66276-66286. , https://doi.org/10.18632/oncotarget.11414
• Mihmanli, M., Ilhan, E., Idiz, U.O., Alemdar, A., Demir, U., Recent developments and innovations in gastric cancer (2016) World J Gastroenterol, 22, pp. 4307-4320. , https://doi.org/10.3748/wjg.v22.i17.4307
• Boidot, R., Vegran, F., Lizard-Nacol, S., Transcriptional regulation of the survivin gene (2014) Mol Biol Rep, 41, pp. 233-240. , https://doi.org/10.1007/s11033-013-2856-0
• Jaiswal, P.K., Goel, A., Mittal, R.D., Survivin: a molecular biomarker in cancer (2015) Indian J Med Res, 141, pp. 389-397. , https://doi.org/10.4103/0971-5916.159250
• Karar, J., Maity, A., PI3K/AKT/mTOR pathway in angiogenesis (2011) Front Mol Neurosci, 4, p. 51. , https://doi.org/10.3389/fnmol.2011.00051
• Fernandez, J.G., Rodriguez, D.A., Valenzuela, M., Calderon, C., Urzua, U., Munroe, D., Rosas, C., Quest, A.F., Survivin expression promotes VEGF-induced tumor angiogenesis via PI3K/Akt enhanced beta-catenin/Tcf-Lef dependent transcription (2014) Mol Cancer, 13, p. 209. , https://doi.org/10.1186/1476-4598-13-209
• Li, B., Senbabaoglu, Y., Peng, W., Yang, M.L., Xu, J., Li, J.Z., Genomic estimates of aneuploid content in glioblastoma multiforme and improved classification (2012) Clin Cancer Res, 18, pp. 5595-5605. , https://doi.org/10.1158/1078-0432.ccr-12-1427
• Sanhueza, C., Wehinger, S., Castillo Bennett, J., Valenzuela, M., Owen, G.I., Quest, A.F., The twisted survivin connection to angiogenesis (2015) Mol Cancer, 14, p. 198. , https://doi.org/10.1186/s12943-015-0467-1
• Abraham, A.G., O'Neill, E., Pi3k/Akt-mediated regulation of p53 in cancer (2014) Biochem Soc Trans, 42, pp. 798-803. , https://doi.org/10.1042/bst20140070
• Bernal, C., Aguayo, F., Villarroel, C., Vargas, M., Diaz, I., Ossandon, F.J., Santibanez, E., Corvalan, A.H., Reprimo as a potential biomarker for early detection in gastric cancer (2008) Clin Cancer Res, 14, pp. 6264-6269. , https://doi.org/10.1158/1078-0432.ccr-07-4522
• Gao, J., Aksoy, B.A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S.O., Sun, Y., Schultz, N., Integrative analysis of complex cancer genomics and clinical profiles using the cbioportal (2013) Sci Signal, 6. , https://doi.org/10.1126/scisignal.2004088
• Zhu, Y., Qiu, P., Ji, Y., TCGA-assembler: open-source software for retrieving and processing tcga data (2014) Nat Methods, 11, pp. 599-600. , https://doi.org/10.1038/nmeth.2956
• Carrasco, G., Diaz, J., Valbuena, J.R., Ibanez, P., Rodriguez, P., Araya, G., Rodriguez, C., Corvalan, A.H., Overexpression of p73 as a tissue marker for high-risk gastritis (2010) Clin Cancer Res, 16, pp. 3253-3259. , https://doi.org/10.1158/1078-0432.ccr-09-2491
• Japanese classification of gastric carcinoma: 3rd English edition (2011) Gastric Cancer, 14, pp. 101-112. , https://doi.org/10.1007/s10120-011-0041-5
• Washington, K., 7th edition of the AJCC cancer staging manual: stomach (2010) Ann Surg Oncol, 17, pp. 3077-3079. , https://doi.org/10.1245/s10434-010-1362-z
• García, C.C., Benavides, C.C., Apablaza, S.P., Rubilar, P.O., Covacevich, S.R., Peñaloza, P.M., Guerra, J.C., Romero, S.C., [Surgical treatment of gastric cancer: results in 423 cases] [Article in Spanish] (2007) Rev Med Chil, 135, pp. 687-695
• Bustin, S.A., Benes, V., Garson, J.A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Wittwer, C.T., The MIQE guidelines: minimum information for publication of quantitative realtime PCR experiments (2009) Clin Chem, 55, pp. 611-622. , https://doi.org/10.1373/clinchem.2008.112797
• Da, C.L., Xin, Y., Zhao, J., Luo, X.D., Significance and relationship between yes-associated protein and survivin expression in gastric carcinoma and precancerous lesions (2009) World J Gastroenterol, 15, pp. 4055-4061
• Ando, K., Oki, E., Saeki, H., Yan, Z., Tsuda, Y., Hidaka, G., Kasagi, Y., Maehara, Y., Discrimination of p53 immunohistochemistrypositive tumors by its staining pattern in gastric cancer (2015) Cancer Med, 4, pp. 75-83. , https://doi.org/10.1002/cam4.346

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------